Reta reta Retatrutide RT10 RT20 1208243-50-8 cas 2381089-83-2 30mg 15mg 10mg 99% RETA

Name: Coco Lee

WA Number:+852 5619 2658

Email: coco@meilipep.com

Retatrutide is a glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide 1 (GLP-1) and glucagon (GCG) multiple receptor agonist. Previous studies have shown that Retatrutide can significantly improve blood sugar control and lipid metabolism in patients with type 2 diabetes (T2D), and also has a powerful weight loss effect!

Mei Li is a professional company specializing in the production of beauty products, healthy products. Mei Li is dedicated to providing the highest standards of product quality and safety compliance.

We closely monitor our customer's compliance programs and adhere to international laws and regulations, including those of the U.S. and Europe. We recognize the challenges posed by geographic distance, language barriers, cultural differences, and the need for on-site quality control and inspection. Hence, we strive to mitigate these challenges, ensuring a seamless and reliable sourcing experience from us.

Choosing us ,you will have a reliable partner, best quality products ,fast and safe delivery ,and worry-free after- sales experience. Sincerely hope that we can have long term cooperative relations with our customers and achieve a win-win situation.

5mg/vial,10vials/box;

10mg/vial,10vials/box;

15mg/vial,10vials/box;

20mg/vial,10vials/box;

30mg/vial,10vials/box;

60mg/vial,10vials/box

100mg/vial,10vials/box

1.What's your payment terms?

Standard terms: T/T in advance and . Also L/C at sight is acceptable for large amount.

2.What's your shipping time?

We have bulk in stock, which means we can ship it to you immediately.

3.How do you ensure the quality of your products?

Strict QC with 6 steps testing from raw material purchase to finished product.

4.How do you ship the order normally?

For large qty order,ship the goods by sea. For small qty order, by air or express. We supply optional express for you, including DHL, FEDEX,UPS,TXT,EMS,and so on.

5.What's your loading port?

Usually Beijing, Shanghai, Qingdao, Tianjin, Guangzhou , HongKong 

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide inhibits human GCGR, GIPR and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively and mouse GCGR, GIPR, and GLP-1R with EC50 values of 2.32, 0.191 and 0.794 nM, respectively. It is an important tool for obesity research.Retatrutide potently activates the GLP-1R signaling pathway to stimulate glucose-dependent insulin secretion through activity at the GIP receptor (GIPR) or the GLP-1R.Retatrutide is a synthetic peptide with glucose-lowering effects. It is an antidiabetic agent against type 2 diabetes (T2D), stimulating insulin and suppressing glucagon secretion in a glucose-dependent manner.Retatrutide was also shown to delay gastric emptying, lower fasting and postprandial glucose concentration, decrease food intake and reduce body weight in patients with type 2 diabetes.
Retatrutide (LY-3437943) was discovered by the American pharmaceutical company Eli Lilly and Company. It is a triple glucagon hormone receptor agonist (GLP-1, GIP, and GCGR receptors) for obesity. The 2024 Lasker~DeBakey Clinical Medical Research Award has been given to Joel Habener and Svetlana Mojsov for their discovery of a new hormone GLP-1(7-37) and to Lotte Knudsen for her role in developing sustained acting versions of this hormone as a treatment for obesity.